Fulminant Myocarditis: When One Size Does Not Fit All - A Critical Review of the Literature.

IF 3.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS European Cardiology Review Pub Date : 2023-04-20 eCollection Date: 2023-01-01 DOI:10.15420/ecr.2022.54
Andrea Silvio Giordani, Anna Baritussio, Cristina Vicenzetto, Maria Grazia Peloso-Cattini, Elena Pontara, Elisa Bison, Chiara Fraccaro, Cristina Basso, Sabino Iliceto, Renzo Marcolongo, Alida Linda Patrizia Caforio
{"title":"Fulminant Myocarditis: When One Size Does Not Fit All - A Critical Review of the Literature.","authors":"Andrea Silvio Giordani, Anna Baritussio, Cristina Vicenzetto, Maria Grazia Peloso-Cattini, Elena Pontara, Elisa Bison, Chiara Fraccaro, Cristina Basso, Sabino Iliceto, Renzo Marcolongo, Alida Linda Patrizia Caforio","doi":"10.15420/ecr.2022.54","DOIUrl":null,"url":null,"abstract":"<p><p>Fulminant myocarditis, rather than being a distinct form of myocarditis, is instead a peculiar clinical presentation of the disease. The definition of fulminant myocarditis has varied greatly in the last 20 years, leading to conflicting reports on prognosis and treatment strategies, mainly because of varied inclusion criteria in different studies. The main conclusion of this review is that fulminant myocarditis may be due to different histotypes and aetiologies that can be diagnosed only by endomyocardial biopsy and managed by aetiology-directed treatment. This life-threatening presentation requires rapid, targeted management both in the short term (mechanical circulatory support, inotropic and antiarrhythmic treatment and endomyocardial biopsy) and in the long term (including prolonged follow-up). Fulminant presentation has also recently been identified as a risk factor for worsened prognosis, even long after the resolution of the acute phase of myocarditis.</p>","PeriodicalId":45957,"journal":{"name":"European Cardiology Review","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2023-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/51/ce/ecr-18-e15.PMC10316338.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Cardiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/ecr.2022.54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Fulminant myocarditis, rather than being a distinct form of myocarditis, is instead a peculiar clinical presentation of the disease. The definition of fulminant myocarditis has varied greatly in the last 20 years, leading to conflicting reports on prognosis and treatment strategies, mainly because of varied inclusion criteria in different studies. The main conclusion of this review is that fulminant myocarditis may be due to different histotypes and aetiologies that can be diagnosed only by endomyocardial biopsy and managed by aetiology-directed treatment. This life-threatening presentation requires rapid, targeted management both in the short term (mechanical circulatory support, inotropic and antiarrhythmic treatment and endomyocardial biopsy) and in the long term (including prolonged follow-up). Fulminant presentation has also recently been identified as a risk factor for worsened prognosis, even long after the resolution of the acute phase of myocarditis.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
暴发性心肌炎:当 "一刀切 "无法解决所有问题时--文献综述。
暴发性心肌炎不是心肌炎的一种独特形式,而是心肌炎的一种特殊临床表现。在过去的 20 年中,对暴发性心肌炎的定义有很大的不同,导致有关预后和治疗策略的报告相互矛盾,这主要是因为不同研究的纳入标准各不相同。本综述的主要结论是,暴发性心肌炎可能由不同的组织型和病因引起,只能通过心内膜活检确诊,并采用病因导向治疗。这种危及生命的表现需要快速、有针对性的短期治疗(机械循环支持、肌力和抗心律失常治疗以及心内膜活检)和长期治疗(包括长期随访)。最近还发现,即使在心肌炎急性期缓解后很长时间,暴发性心肌炎也是导致预后恶化的一个危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Cardiology Review
European Cardiology Review CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
5.40
自引率
0.00%
发文量
23
审稿时长
12 weeks
期刊最新文献
Cardiovascular Drug Interactions with Nirmatrelvir/Ritonavir for COVID-19: Considerations for Daily Practice The Effects of Co-injecting Human iPSC-Derived Cardiomyocytes/Pre-epicardial Cells into Cryoinjured Rat Hearts The Impact of Renin–Angiotensin System Inhibitor Use on Clinical Outcomes by GRACE Score in ST-elevation MI Patients Undergoing Successful Percutaneous Coronary Intervention with Drug-eluting Stents Assessment of Direct Oral Anticoagulant Use and Clinical Outcomes among Patients with Renal Impairment at Faculty of Medicine Siriraj Hospital, Mahidol University Actual Condition of Transthyretin Amyloid Cardiac Amyloidosis: Single Centre Experience
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1